Base
Notice2024-174312024-08-07

Pesticides; Emergency Order Suspending the Registrations of All Pesticide Products Containing Dimethyl Tetrachloroterephthalate (DCPA)

Environmental Protection Agency

Abstract

The Environmental Protection Agency (EPA or Agency) is issuing an Emergency Order directing the suspension of all registrations issued under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) for pesticide products containing the active ingredient dimethyl tetrachloroterephthalate (DCPA), also marketed under the trade name Dacthal. EPA has determined that continued sale, distribution, or use of DCPA products during the time required to cancel such products would pose an imminent hazard and that an emergency exists that does not permit EPA to hold a hearing before suspending such products. These determinations are based primarily on a risk of thyroid hormone perturbations in the fetuses of female bystanders and workers who apply DCPA or who enter treated fields after application. EPA has concerns that pregnant individuals may be currently exposed to DCPA at levels higher than those that cause fetal thyroid hormone disruption, but at which no thyroid effects would occur in the pregnant individual. The downstream effects of such hormone perturbations in the fetus may include low birth weight and irreversible and life-long impacts to children exposed in-utero, such as impaired brain development and motor skills. While the sole registrant of DCPA products, AMVAC Chemical Corporation (AMVAC), has attempted to address these concerns, EPA has determined that there is no combination of practicable mitigations under which DCPA use can continue without presenting an imminent hazard. Set forth below are the substantive bases for these determinations and the procedures that affected registrants must follow to obtain a hearing on or otherwise challenge these determinations.

Action & Dates

Action
Order.
Dates
This Emergency Order is issued and effective immediately upon signature. The sole affected registrant has also been notified by certified mail. Any request by the registrant for a hearing on the issue of whether an imminent hazard exists must be received by the Clerk of the EPA Office of Administrative Law Judges (OALJ). A copy of the Emergency Order has been filed with the OALJ Clerk.

Document Excerpt

Document Headings Document headings vary by document type but may contain the following: the agency or agencies that issued and signed a document the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to the agency docket number / agency internal file number the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions See the Document Drafting Handbook for more details. Environmental Protection Agency [EPA-HQ-OPP-2011-0374; FRL-12147-01-OCSPP] AGENCY: Environmental Protection Agency (EPA). ACTION: Order. SUMMARY: The Environmental Protection Agency (EPA or Agency) is issuing an Emergency Order directing the suspension of all registrations issued under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) for pesticide products containing the active ingredient dimethyl tetrachloroterephthalate (DCPA), also marketed under the trade name Dacthal. EPA has determined that continued sale, distribution, or use of DCPA products during the time required to cancel such products would pose an imminent hazard and that an emergency exists that does not permit EPA to hold a hearing before suspending such products. These determinations are based primarily on a risk of thyroid hormone perturbations in the fetuses of female bystanders and workers who apply DCPA or who enter treated fields after application. EPA has concerns that pregnant individuals may be currently exposed to DCPA at levels higher than those that cause fetal thyroid hormone disruption, but at which no thyroid effects would occur in the pregnant individual. The downstream effects of such hormone perturbations in the fetus may include low birth weight and irreversible and life-long impacts to children exposed in-utero, such as impaired brain development and motor skills. While the sole registrant of DCPA products, AMVAC Chemical Corporation (AMVAC), has attempted to address these co

Read full document on FederalRegister.gov →

Related Documents

Other Federal Register documents from the same docket.

Full Document

Citation: 89 FR 64445